NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease
A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

NCT00099203

TerminatedPhase 3

Sponsor: Hoffmann-La Roche

Conditions: Pain, Bone Neoplasm, Neoplasm Metastasis

Interventions: ibandronate [Bondronat], zoledronic acid

Countries: United States, Argentina, Australia, Belgium, Canada, Chile, France, Germany

This 2 arm study will compare the efficacy of intravenous Bondronat with that of zoledronic acid in patients with malignant bone disease experiencing moderate to severe pain. Patients will be randomized to receive either Bondronat (6mg iv on days 1, 2 and 3 and then every 3-4 weeks) or zoledronic acid (4mg iv on day 1 and then every 3-4 weeks). The anticipated time of study treatment is 6-12 months, and the target sample size is 100-500 individuals.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* patients with malignant bone disease;
* patients with moderate to severe pain.

Exclusion Criteria:

* patients who have received a bisphosphonate within 3 weeks from the signing of the informed consent;
* patients receiving concurrent investigational therapy, or who have received investigational therapy within 30 days of the first scheduled day of dosing;
* untreated esophagitis or gastric ulcers;
* recent or pre-scheduled radiotherapy to bone;
* patients who are pregnant or breast-feeding.
Locations (72)
  • Birmingham, Alabama, United States
  • Sedona, Arizona, United States
  • Ocoee, Florida, United States
  • Macon, Georgia, United States
  • Galesburg, Illinois, United States
  • Indianapolis, Indiana, United States
  • Kansas City, Missouri, United States
  • Henderson, Nevada, United States
  • Reno, Nevada, United States
  • Albany, New York, United States
  • Oklahoma City, Oklahoma, United States
  • Eugene, Oregon, United States
  • Nashville, Tennessee, United States
  • Abilene, Texas, United States
  • Arlington, Texas, United States
  • Beaumont, Texas, United States
  • Dallas, Texas, United States
  • Dallas, Texas, United States
  • Fort Worth, Texas, United States
  • Fredericksburg, Texas, United States
  • Longview, Texas, United States
  • Round Rock, Texas, United States
  • Norfolk, Virginia, United States
  • Seattle, Washington, United States
  • Spokane, Washington, United States
  • Vancouver, Washington, United States
  • Buenos Aires, Argentina
  • Buenos Aires, Argentina
  • Buenos Aires, Argentina
  • La Plata, Argentina
  • + 42 more on CT.gov